The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

Q1 2025 Management View CEO Jon Rousseau highlighted that BrightSpring achieved Q1 revenue of $2.9 billion, marking 26% year-over-year growth, with adjusted EBITDA of $131 million, up 28%. Pharmacy ...

BrightSpring Health Services’ (Nasdaq: BTSG) leadership team spent Friday morning fielding questions about the news that Amedisys (Nasdaq: AMED) reached ...

BrightSpring, which has pharmacy services and health provider services focused on senior and specialty populations, said revenue rose 26% to $2.88 billion. Analysts polled by FactSet expected $2.71 ...

We've discovered 2 warning signs about BrightSpring Health Services. View them for free. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 84%.

BrightSpring Health Services, Inc.’s BTSG share price has surged by 11.06%, which has investors questioning if this is right ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...

The companies said they have an agreement to sell home health and hospice locations to BrightSpring Health Services and The ...

Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Welcome to the BrightSpring Health Services, Inc. Common Stock First Quarter 2025 Earnings Conference Call. At this ...

Shares of BrightSpring Health were trading at $17.53 as of April 30. Over the last 52-week period, shares are up 58.35%.